A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients.
暂无分享，去创建一个
S. Pileri | M. Baccarani | S. Fanti | P. Zinzani | P. Zinzani | E. Derenzini | L. Alinari | M. Farsad | P. Castellucci | P. Castellucci | F. Bacci | A. de Vivo | E. Marchi | V. Stefoni | M. Tani | G. Musuraca | C. Pellegrini | M. Fina | A. Vivo